» Authors » Koichi Tokuda

Koichi Tokuda

Explore the profile of Koichi Tokuda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 538
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Baba H, Kanamori H, Nakayama A, Sato T, Katsumi M, Chida T, et al.
Antimicrob Steward Healthc Epidemiol . 2024 May; 4(1):e86. PMID: 38774118
Objective: This study aimed to investigate and contain a cluster of invasive candidiasis cases caused by fluconazole-resistant (FRC) in a neonatal intensive care unit. Methods: Active surveillance was initiated. Direct...
2.
Nogawa S, Kanamori H, Tokuda K, Kawafune K, Chijiiwa M, Saito K, et al.
Sci Rep . 2023 Nov; 13(1):20820. PMID: 38012279
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide. To prevent its spread, mRNA-based vaccines made by Pfizer/BioNTech (BNT162b1) and Moderna (mRNA-1273) have been widely used, including in Japan....
3.
Takei K, Kanamori H, Nakayama A, Chiba M, Takei Y, Seike I, et al.
Antibiotics (Basel) . 2023 Jul; 12(7). PMID: 37508242
Metallo-beta-lactamases (MBLs) are enzymes that break down carbapenem antibiotics, leading to carbapenem-resistant organisms. Carbapenemase-resistant (CRE) is one of them. Outbreaks of CRE infection can occur in healthcare facilities and lead...
4.
Akaishi T, Tokuda K, Katsumi M, Fujimaki S, Aoyagi T, Harigae H, et al.
Cureus . 2023 Jul; 15(6):e40202. PMID: 37435240
Background Central line-associated bloodstream infection (CLABSI) is among the most common bloodstream infections in the university hospital and intensive care unit settings. This study evaluated the routine blood test findings...
5.
Iwasaki Y, Takei Y, Yamada M, Sugino S, Saito K, Aoyagi T, et al.
J Clin Med . 2023 May; 12(10). PMID: 37240566
Coronavirus disease 2019 (COVID-19) is associated with coagulopathy. However, the underlying mechanisms are not completely understood. We evaluated the association between COVID-19 coagulopathy and extracellular vesicle (EV) levels. We hypothesized...
6.
Kitaya S, Baba H, Okamoto M, Sakamoto M, Nakayama A, Takei Y, et al.
J Travel Med . 2023 May; 30(5). PMID: 37158457
No abstract available.
7.
Fukuda K, Baba H, Yoshida M, Kitabayashi K, Katsushima S, Sonehara H, et al.
Microorganisms . 2023 Apr; 11(4). PMID: 37110367
The assessment of airborne viruses in air is a critical step in the design of appropriate prevention and control measures. Hence, herein, we developed a novel wet-type electrostatic air sampler...
8.
Kitaya S, Kanamori H, Katori Y, Tokuda K
Microorganisms . 2023 Apr; 11(4). PMID: 37110351
The clinical distinctions among variations in species, antifungal resistance (AFR), and clearance status of hospital-acquired persistent candidemia (HA-PC) remain uncertain. This secondary analysis of a retrospective cohort study aimed to...
9.
Kitaya S, Kanamori H, Katori Y, Tokuda K
Antibiotics (Basel) . 2023 Mar; 12(3). PMID: 36978326
Clinical outcomes of persistent staphylococcal bacteremia vary depending on the causative organism. This secondary data analysis study compared the clinical characteristics of persistent ()- and coagulase-negative staphylococci (CoNS)-caused bacteremia, focusing...
10.
Kitaya S, Kanamori H, Baba H, Oshima K, Takei K, Seike I, et al.
Pathogens . 2023 Feb; 12(2). PMID: 36839484
: Bloodstream infections (BSIs), including persistent bacteremia (PB), are a leading source of morbidity and mortality globally. PB has a higher mortality rate than non- PB, but the clinical aspects...